In a first-of-its-kind clinical trial, U.S. researchers have found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana – THC and CBD – had significantly less agitation compared to people who received a placebo. The primary findings of the study were presented July 14, 2026, at the Alzheimer’s Association International Conference in London.

New research out of VCU Massey Comprehensive Cancer Center provides promising evidence for an innovative combination treatment strategy that uses cells’ waste removal functions to effectively dismantle multiple myeloma. The findings, published recently in Cell Death & Disease, show how an experimental targeted protein degrader, developed in-house at the cancer center, enhances the destruction of a specific cancer cell survival protein and works in tandem with existing drugs in preclinical models, while showing limited toxicity in cardiac models.